Salivary Therapeutic Drug Monitoring of Antimicrobial Therapy: Feasible or Futile? Lina Davies ForsmanHannah Yejin KimJan-Willem C. Alffenaar Current Opinion Open access 01 February 2024 Pages: 269 - 278
Toward Genetic Testing of Rivaroxaban? Insights from a Systematic Review on the Role of Genetic Polymorphism in Rivaroxaban Therapy Yi MaZaiwei SongZhanmiao Yi Systematic Review 09 March 2024 Pages: 279 - 291
Safety and Pharmacokinetics of HRS-2261, a P2X3 Receptor Antagonist, in Healthy Subjects: A Randomized, Double-Blind, Placebo-Controlled Phase 1 Study Yuru FanXuan ZhangWei Hu Original Research Article 10 January 2024 Pages: 293 - 302
Population Pharmacokinetic/Pharmacodynamic Models for P2Y12 Inhibitors: A Systematic Review and Clinical Appraisal Using Exposure Simulation Jingcheng ChenYuchen QuDongyang Liu Original Research Article 20 January 2024 Pages: 303 - 316
Maternal Ezetimibe Concentrations Measured in Breast Milk and Its Use in Breastfeeding Infant Exposure Predictions Cindy H. T. YeungJulie AutmizguineAndrea N. Edginton Original Research Article 26 January 2024 Pages: 317 - 332
Lumacaftor/Ivacaftor Population Pharmacokinetics in Pediatric Patients with Cystic Fibrosis: A First Step Toward Personalized Therapy Naïm BouazzaSaïk UrienIsabelle Sermet-Gaudelus Original Research Article 04 February 2024 Pages: 333 - 342
Towards More Robust Evaluation of the Predictive Performance of Physiologically Based Pharmacokinetic Models: Using Confidence Intervals to Support Use of Model-Informed Dosing in Clinical Care Marjolein D. van BorselenLaurens Auke Æmiel SluijtermanSaskia N. de Wildt Original Research Article Open access 15 February 2024 Pages: 343 - 355
A Population Pharmacokinetic Analysis of l-Glutamine Exposure in Patients with Sickle Cell Disease: Evaluation of Dose and Food Effects Alina SadafMin DongCharles T. Quinn Original Research Article Open access 24 February 2024 Pages: 357 - 365
Bayesian Vancomycin Model Selection for Therapeutic Drug Monitoring in Neonates Dua’a AlrahahlehYann ThomaJan-Willem Alffenaar Original Research Article Open access 28 February 2024 Pages: 367 - 380
Moving Beyond Boundaries: Utilization of Longitudinal Exposure–Response Model for Bounded Outcome Score to Inform Decision Making in the Accelerated Drug Development Paradigm Yeamin HuhJessica WojciechowskiVivek S. Purohit Original Research Article Open access 15 February 2024 Pages: 381 - 394
Comment on: Anti-Coagulant Treatment of Cancer-Associated Thrombosis in Frail Patients: Impact of Frailties on the Management of Drug–Drug Interactions Lorenz Van der LindenThomas VanasschePeter Verhamme Letter to the Editor 18 January 2024 Pages: 395 - 396